Extracting hydroxyapatite and its precursors from natural resources

Healing of segmental bone defects remain a difficult problem in orthopedic and trauma surgery. One reason for this difficulty is the limited availability of bone material to fill the defect and promote bone growth. Hydroxyapatite (HA) is a synthetic biomaterial, which is chemically similar to the mineral component of bones and hard tissues in mammals and, therefore, it can be used as a filler to replace damaged bone or as a coating on implants to promote bone in-growth into prosthetic implants when used in orthopedic, dental, and maxillofacial applications. HA is a stoichiometric material with a chemical composition of Ca10(PO4)6(OH)2, while a mineral component of bone is a non-stoichiometric HA with trace amounts of ions such as Na+, Zn2+, Mg2+, K+, Si2+, Ba2+, F-, CO3 2-, etc. This review looks at the progress being made to extract HA and its precursors containing trace amount of beneficial ions from biological resources like animal bones, eggshells, wood, algae, etc. Properties, such as particle size, morphology, stoichiometry, thermal stability, and the presence of trace ions are studied with respect to the starting material and recovery method used. This review also highlights the importance of extracting HA from natural resources and gives future directions to the researcher so that HA extracted from biological resources can be used clinically as a valuable biomaterial

Recipient factors in faecal microbiota transplantation: one stool does not fit all

International audienceFaecal microbiota transplantation (FMT) is a promising therapy for chronic diseases associated with gut microbiota alterations. FMT cures 90% of recurrent Clostridioides difficile infections. However, in complex diseases, such as inflammatory bowel disease, irritable bowel syndrome and metabolic syndrome, its efficacy remains variable. It is accepted that donor selection and sample administration are key determinants of FMT success, yet little is known about the recipient factors that affect it. In this Perspective, we discuss the effects of recipient parameters, such as genetics, immunity, microbiota and lifestyle, on donor microbiota engraftment and clinical efficacy. Emerging evidence supports the possibility that controlling inflammation in the recipient intestine might facilitate engraftment by reducing host immune system pressure on the newly transferred microbiota. Deciphering FMT engraftment rules and developing novel therapeutic strategies are priorities to alleviate the burden of chronic diseases associated with an altered gut microbiota such as inflammatory bowel disease